Ticagrelor Versus Clopidogrel in Large Vessel Ischemic Stroke

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 580 participants.

Also called NCT06120725

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 580 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06120725
Other papers using this trial's data
  • Ticagrelor Versus Clopidogrel in Acute Large-Vessel Ischemic Stroke: A Randomized Controlled Single-Blinded Trial CNS drugs, 2024-05 DOI, PubMed 38619649, PMC11026220 In the PMC Open Access subset under CC BY-NC.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Egypt (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06120725. Randomized; double masking; primary purpose treatment. Start 2021-09-01 (actual); primary completion 2023-09-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ticagrelor Versus Clopidogrel in Large Vessel Ischemic Stroke
Intervention (Drug)
Ticagrelor 90 MG
Intervention (Drug)
Clopidogrel
Lead sponsor
Kafrelsheikh University (class: other)

Record details

Record id
cardio:ct-nct06120725
Content hash
fd428d370fd301c109888fbad88970c036434a14236e700351923419cf8962c8